Dificid (fidaxomicin)

Manufacturer:
Merck
Route of Administration: 
Oral
Site of Care:
Outpatient
Website: 
  • Manufacturer Website
Enrollment Forms:
Synergen Prescription Form

Approved Indication:

treatment of Clostridium difficile-associated diarrhea in adults and pediatric patients 6 months of age and older

Conditions:

  • C. Difficile Diarrhea

Therapeutic Area:

  • Infectious disease